CleanSpace Shares Industry Insights in Philadelphia Business Journal

CleanSpace recently shared its perspective with the Philadelphia Business Journal on a critical challenge shaping the life sciences industry. As therapies grow more complex and regulatory expectations continue to rise, facility decisions are carrying far greater long-term weight than traditional risk models account for.

The article explores how fragmented delivery models create gaps across organizations, disciplines, and project phases that can impact facility performance and compliance well beyond construction. CleanSpace makes the case for an integrated design-build approach, one that aligns planning, regulatory requirements, and operational goals under a single accountable structure to reduce risk and support long-term facility performance.

This piece reflects CleanSpace's ongoing commitment to helping life sciences organizations rethink how controlled environments are designed, built, and maintained.